Downregulation of oxytocin receptors in right ventricle of rats with monocrotaline-induced pulmonary hypertension

Acta Physiologica

Volumn 200, Issue 2, 2010, Pages 147-158

  Broderick, T L ^a   Wang, Y ^b   Gutkowska, J ^b   Wang, D ^b   Jankowski, M ^b  

^a MIDWESTERN UNIVERSITY   (United States)

^b CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

inflammation; monocrotaline; natriuretic peptides; nitric oxide; oxytocin; receptors

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MONOCROTALINE; NATRIURETIC PEPTIDE RECEPTOR A; NATRIURETIC PEPTIDE RECEPTOR B; NITRIC OXIDE SYNTHASE; OXYTOCIN RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEART RIGHT VENTRICLE; HEART RIGHT VENTRICLE HYPERTROPHY; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PULMONARY HYPERTENSION; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BLOTTING, WESTERN; DOWN-REGULATION; GENE EXPRESSION; HEART VENTRICLES; HYPERTENSION, PULMONARY; MALE; MONOCROTALINE; OXYTOCIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OXYTOCIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 77956327017     PISSN: 17481708     EISSN: 17481716     Source Type: Journal    
DOI: 10.1111/j.1748-1716.2010.02134.x     Document Type: Article

References (66)

1. Abel, E.D., Graveleau, C., Betuing, S., Pham, M., Reay, P.A., Kandror, V., Kupriyanova, T., Xu, Z. Kandror, K.V. 2004. Regulation of insulin-responsive aminopeptidase expression and targeting in the insulin-responsive vesicle compartment of glucose transporter isoform 4-deficient cardiomyocytes. Mol Endocrinol 18, 2491 2501.
2. Akhavein, F., St-Michel, E.J., Seifert, E. Rohlicek, C.V. 2007. Decreased left ventricular function, myocarditis, and coronary arteriolar medial thickening following monocrotaline administration in adult rats. J Appl Physiol 103, 287 295.
3. Anker, S.D. von Haehling, S. 2004. Inflammatory mediators in chronic heart failure: an overview. Heart 90, 464 470.
4. Balligand, J.L., Ungureanu, D., Kelly, R.A., Kobzik, L., Pimental, D., Michel, T. Smith, T.W. 1993. Abnormal contractile function due to induction of nitric oxide synthesis in rat cardiac myocytes follows exposure to activated macrophage-conditioned medium. J Clin Invest 91, 2314 2319.
5. Broderick, T.L. King, T.M. 2008. Upregulation of GLUT4 in right ventricle of rats with monocrotaline-induced model of pulmonary hypertension. Med Sci Monit 14, 261 264.
6. Buitrago, M., Lorenz, K., Maass, A.H., Oberdorf-Maass, S., Keller, U., Schmitteckert, E.M., Ivashchenko, Y., Lohse, M.J. Engelhardt, S. 2005. The transcriptional repressor Nab1 is a specific regulator of pathological cardiac hypertrophy. Nat Med 11, 837 844.
7. Chai, S.Y., Fernando, R., Peck, G., Ye, S.Y., Mendelsohn, F.A., Jenkins, T.A. Albiston, A.L. 2004. The angiotensin IV/AT4 receptor. Cell Mol Life Sci 61, 2728 2737.
8. Chandler, M.P., Kerner, J., Huang, H., Vazquez, E., Reszko, A., Martini, W.Z., Hoppel, C.L., Imai, M., Rastogi, S., Sabbah, H.N. Stanley, W.C. 2004. Moderate severity heart failure does not involve a downregulation of myocardial fatty acid oxidation. Am J Physiol Heart Circ Physiol 287, H1538 H1543.
9. Combes, A., Frye, C.S., Lemster, B.H., Brooks, S.S., Watkins, S.C., Feldman, A.M. McTiernan, C.F. 2002. Chronic exposure to interleukin 1beta induces a delayed and reversible alteration in excitation-contraction coupling of cultured cardiomyocytes. Pflugers Arch 445, 246 256.
10. D'Alonzo, G.E., Barst, R.J., Ayres, S.M., Bergofsky, E.H., Brundage, B.H., Detre, K.M., Fishman, A.P., Goldring, R.M., Groves, B.M., Kernis, J.T. et al. 1991. Survival in patients with primary pulmonary hypertension: results from a national prospective registry. Ann Intern Med 115, 343 349.
11. Deswal, A., Petersen, N.J., Feldman, A.M., Young, J.B., White, B.G. Mann, D.L. 2001. Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation 103, 2055 2059.
12. Florian, M., Jankowski, M. Gutkowska, J. 2010. Oxytocin increases glucose uptake in neonatal rat cardiomyocytes. Endocrinology 151, 482 491.
13. Frangogiannis, N.G. 2008. The immune system and cardiac repair. Pharmacol Res 58, 88 111.
14. Fujita, M., Mason, R.J., Cool, C., Shannon, J.M., Hara, N. Fagan, K.A. 2002. Pulmonary hypertension in TNF-alpha-overexpressing mice is associated with decreased VEGF gene expression. J Appl Physiol 93, 2162 2170.
15. Gulick, T., Chung, M.K., Pieper, S.J., Lange, L.G. Schreiner, G.F. 1989. Interleukin 1 and tumor necrosis factor inhibit cardiac myocyte beta-adrenergic responsiveness. Proc Natl Acad Sci USA 86, 6753 6757.
16. Gutkowska, J. Jankowski, M. 2008. Oxytocin revisited: it is also a cardiovascular hormone. J Am Soc Hypertens 2, 318 325.
17. Gutkowska, J., Jankowski, M., Lambert, C., Mukaddam-Daher, S., Zingg, H.H. McCann, S.M. 1997. Oxytocin releases atrial natriuretic peptide by combining with oxytocin receptors in the heart. Proc Natl Acad Sci USA 94, 11704 11709.
18. Gutkowska, J., Broderick, T.L., Bogdan, D., Wang, D., Lavoie, J.M. Jankowski, M. 2009. Downregulation of oxytocin and natriuretic peptides in diabetes: possible implications in cardiomyopathy. J Physiol 587, 4725 4736.
19. Haanwinckel, M.A., Elias, L.K., Favaretto, A.L., Gutkowska, J., McCann, S.M. Antunes-Rodrigues, J. 1995. Oxytocin mediates atrial natriuretic peptide release and natriuresis after volume expansion in the rat. Proc Natl Acad Sci USA 92, 7902 7906.
20. Hardziyenka, M., Campian, M.E., Rianne de Bruin-Bon, H.A.M.C., Michel, M.C. Tan, H.L. 2006. Sequence of echocardiographic changes during development of right ventricular failure in rat. J Am Soc Echocardiogr 19, 1272 1279.
21. Hirota, H., Yoshida, K., Kishimoto, T. Taga, T. 1995. Continuous activation of gp 130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice. Proc Natl Acad Sci USA 92, 4862 4866.
22. Honda, M., Yamada, S., Goto, Y., Ishikawa, S., Yoshikane, H., Ishinaga, Y., Kuzuo, H., Morioka, S. Moriyama, K. 1992. Biochemical and structural remodelling of collagen in the right ventricular hypertrophy induced by monocrotaline. Jpn Circ J 56, 392 403.
23. Hosenpud, J.D. 1993. The effects of interleukin-1 on myocardial function and metabolism. Clin Immunol Immunopathol 68, 175 180.
24. Humbert, M., Monti, G., Brenot, F., Sitbon, O., Portier, A., Grangeot-Keros, L., Duroux, P., Galanaud, P., Simonneau, G. Emilie, D. 1995. Increased interleukin-1 and interleukin-6 serum concentrations in severe primary pulmonary hypertension. Am J Respir Crit Care Med 151, 1628 1631.
25. Inoue, Y., Kawayama, T., Iwanaga, T. Aizawa, H. 2009. High plasma brain natriuretic peptide levels in stable COPD without pulmonary hypertension or cor pulmonale. Intern Med 48, 503 512.
26. Jankowski, M., Hajjar, F., Kawas, S.A., Mukaddam-Daher, S., Hoffman, G., McCann, S.M. Gutkowska, J. 1998. Rat heart: a site of oxytocin production and action. Proc Natl Acad Sci USA 95, 14558 14563.
27. Jankowski, M., Danalache, B., Wang, D., Bhat, P., Hajjar, F., Marcinkiewicz, M., Paquin, J., McCann, S.M. Gutkowska, J. 2004. Oxytocin in cardiac ontogeny. Proc Natl Acad Sci USA 101, 13074 13079.
28. Jankowski, M., Bissonauth, V., Gao, L., Gangal, M., Wang, D., Danalache, B., Wang, Y., Stoyanova, E., Cloutier, G., Blaise, G. Gutkowska, J. 2010. Anti-inflammatory effect of oxytocin in rat myocardial infarction. Basic Res Cardiol 105, 205 218.
29. Joppa, P., Petrasova, D., Stancak, B. Tkacova, R. 2006. Systemic inflammation in patients with COPD and pulmonary hypertension. Chest 130, 326 333.
30. Kobayashi, H., Yasuda, S., Bao, N., Iwasa, M., Kawamura, I., Yamada, Y., Yamaki, T., Sumi, S., Ushikoshi, H., Nishigaki, K., Takemura, G., Fujiwara, T., Fujiwara, H. Minatoguchi, S. 2009. Post-infarct treatment with oxytocin improves function and remodeling via activating cell survival signals and angiogenesis. J Cardiovascul Pharmacol 54, 510 519.
31. Lamberts, R.R., Vaessen, R.K., Westerhof, N. Stienen, G.J.M. 2007. Right ventricular hypertrophy causes impairment of left ventricular diastolic function in the rat. Basic Res Cardiol 102, 19 27.
32. Li, Y.Y., Feng, Y.Q., Kadokami, T., McTiernan, C.F., Draviam, R., Watkins, S.C. Feldman, A.M. 2000. Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor necrosis factor α can be modulated by anti-tumor necrosis factor α therapy. Proc Natl Acad Sci USA 97, 12746 12751.
33. Li, C., Wang, W., Summer, S.N., Westfall, T.D., Brooks, D.P., Falk, S. Schrier, R.W. 2008. Molecular mechanisms of antidiuretic effect of oxytocin. J Am Soc Nephrol 19, 225 232.
34. London, B. 2006. Natriuretic peptides and cardiac hypertrophy. J Am Coll Cardiol 48, 506 507.
35. Lourenço, A.P., Roncon-Albuquerque, R., Jr., Brás-Silva, C., Faria, B., Wieland, J., Henriques-Coelho, T., Correia-Pinto, J. Leite-Moreira, A.F. 2006. Myocardial dysfunction and neurohumoral activation without remodeling in left ventricle of monocrotaline-induced pulmonary hypertensive rats. Am J Physiol Heart Circ Physiol 291, H1587 H1594.
36. Malave, H.A., Taylor, A.A., Nattama, J., Deswal, A. Mann, D.L. 2003. Circulating levels of tumor necrosis factor correlate with indexes of depressed heart rate variability: a study in patients with mild-to-moderate heart failure. Chest 123, 716 724.
37. Mann, D.L. 2002. Inflammatory mediators and the failing heart: past, present, and the foreseeable future. Circ Res 91, 988 998.
38. Miyata, M., Sakuma, F., Yoshimura, A., Ishikawa, H., Nishimaki, T. Kasukawa, R. 1995. Pulmonary hypertension in rats. 2. Role of interleukin-6. Int Arch Allergy Immunol 108, 287 291.
39. Miyauchi, T., Yorikane, R., Sakai, S., Sakurai, T., Okada, M., Nishikibe, M., Yano, M., Yamaguchi, I., Sugishita, Y. Goto, K. 1993. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res 73, 887 897.
40. Mukaddam-Daher, S., Yin, Y.L., Roy, J., Gutkowska, J. Cardinal, R. 2001. Negative inotropic and chronotropic effects of oxytocin. Hypertension 38, 292 296.
41. Neubauer, S. 2007. The failing heart - an engine out of fuel. N Engl J Med 256, 1140 1151.
42. Oikawa, M., Kagaya, Y., Otani, H., Sakuma, M., Demachi, J., Suzuki, J., Takahashi, T., Nawata, J., Ido, T., Watanabe, J. Shirato, K. 2005. Increased [18F] fluorodeoxyglucose accumulation in right ventricular free wall in patients with pulmonary hypertension and the effect of epoprostenol. J Am Coll Cardiol 45, 1849 1855.
43. Ondrejcakova, M., Ravingerova, T., Bakos, J., Pancza, D. Jezova, D. 2009. Oxytocin exerts protective effects on in vitro myocardial injury induced by ischemia and reperfusion. Can J Physiol Pharmacol 87, 137 142.
44. Osorio, J.C., Stanley, W.C., Linke, A., Castellari, M., Diep, Q.N., Panchal, A.R., Hintze, T.H., Lopaschuk, G.D. Recchia, F.A. 2002. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid x receptor-α in pacing-induced heart failure. Circulation 106, 606 612.
45. Palmer, J.N., Hartogensis, W.E., Patten, M., Fortuin, F.D. Long, C.S. 1995. Interleukin-1 β induces cardiac myocyte growth but inhibits cardiac fibroblast proliferation in culture. J Clin Invest 95, 2555 2564.
46. Petersson, M. 2002. Cardiovascular effects of oxytocin. Prog Brain Res 139, 281 288.
47. Piao, L., Fang, Y.-H., Cadette, V.J.J., Wietholt, C., Urboniene, D., Toth, P.T., Marsboom, G., Zhang, H.J., Haber, I., Rehman, J., Lopaschuk, G.D. Archer, S.L. 2010. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. J Mol Med 88, 47 60.
48. Razeghi, P., Young, M.E., Alcorn, J.L., Moravec, C.S., Frazier, O.H. Taegtmeyer, H. 2001. Metabolic gene expression in fetal and failing human heart. Circulation 104, 2923 2931.
49. Remondino, A., Rosenblatt-Velin, N., Montessuit, C., Tardy, I., Papageorgiou, I., Dorsaz, P.A., Jorge-Costa, M. Lerch, R. 2000. Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction. Altered expression of proteins of metabolic regulation during remodeling of the left ventricle after myocardial infarction. J Mol Cell Cardiol 32, 2025 2034.
50. Roncon-Albuquerque, R., Jr., Vasconcelos, M., Lourenço, A.P., Brandao-Nogueira, A., Teles, A., Henriques-Coelho, T. Leite-Moreira, A.F. 2006. Acute changes of biventricular gene expression in volume and right ventricular pressure overload. Life Sci 78, 2633 2642.
51. Rosenberg, H.C. Rabinovitch, M. 1988. Endothelial injury and vascular reactivity in monocrotaline pulmonary hypertension. Am J Physiol 255, H1484 H1491.
52. Sasayama, S., Matsumori, A. Kihara, Y. 1999. New insights into the pathophysiological role for cytokines in heart failure. Cardiovasc Res 42, 557 564.
53. Schäfer, S., Ellinghaus, P., Janssen, W., Kramer, F., Listig, K., Milting, H., Kast, R. Klein, M. 2009. Chronic inhibition of phosphodiesterase 5 does not prevent pressure-overloaded-induced right-ventricular remodelling. Cardiovasc Res 82, 30 39.
54. Schermuly, R.T., Kreisselmeier, K.P., Ghofrani, H.A., Yilmaz, H., Butrous, G., Ermert, L., Ermert, M., Weissmann, N., Rose, F., Guenther, A., Walmrath, D., Seeger, W. Grimminger, F. 2004. Chronic sildenafil treatment inhibits monocrotaline-induced pulmonary hypertension in rats. Am J Respir Crit Care Med 169, 39 45.
55. Schmid, B., Wong, S. Mitchel, B.F. 2001. Transcriptional regulation of oxytocin receptor by interleukin-1beta and interleukin-6. Endocrinology 142, 1380 1385.
56. Schulz, R., Panas, D.L., Catena, R., Moncada, S., Olley, P.M. Lopaschuk, G.D. 1995. The role of nitric oxide in cardiac depression induced by interleukin-1 beta and tumour necrosis factor-alpha. Br J Pharmacol 114, 27 34.
57. Strauss, B.H. Rabinovitch, M. 2000. Adventitial fibroblasts: defining a role in vessel wall remodeling. Am J Respir Cell Mol Biol 20, 1 3.
58. Taylor, M., Wallhaus, T.R., Delgrado, T.R., Russell, D.C., Stanko, P., Nickles, R.J. Stone, C.K. 2001. An evaluation of myocardial fatty acid and glucose uptake using PET with [18F]fluoro-6-thia-heptadecanoic acid and [18F]FDG in patients with congestive heart failure. J Nucl Med 42, 55 62.
59. Thaik, C.M., Calderone, A., Takahashi, N. Colucci, W.S. 1995. Interleukin-1 β modulates the growth and phenotype of neonatal rat cardiac myocytes. J Clin Invest 96, 1093 1099.
60. Tsujino, M., Hirata, Y., Imai, T., Kanno, K., Eguchi, S., Ito, H. Marumo, F. 1994. Induction of nitric oxide synthase gene by interleukin-1 β in cultured rat cardiocytes. Circulation 90, 375 383.
61. Tuder, R.M., Chacon, M., Alger, L., Wang, J., Taraseviciene-Stewart, L., Kasahara, Y., Cool, C.D., Bishop, A.E., Geraci, M., Semenza, G.L., Yacoub, M., Polak, J.M. Voelkel, N.F. 2001. Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis. J Pathol 195, 367 374.
62. Usui, S., Yao, A., Hatano, M., Kohmoto, O., Takahashi, T., Nagai, R. Kinugawa, K. 2006. Upregulated neurohumoral factors are associated with left ventricular remodeling and poor prognosis in rats with monocrotaline-induced pulmonary arterial hypertension. Circ J 70, 1208 1215.
63. Voelkel, N.F., Tuder, R.M., Bridges, J. Arend, W.P. 1994. Interleukin-1 receptor antagonist treatment reduces pulmonary hypertension generated in rats by monocrotaline. Am J Respir Cell Mol Biol 11, 664 675.
64. Werchan, P.M., Summer, W.R., Gerdes, A.M. McDonough, K.H. 1989. Right ventricular performance after monocrotaline-induced pulmonary hypertension. Am J Physiol 256, H1328 H1336.
65. Yi, E.S., Kim, H., Ahn, H., Strother, J., Morris, T., Masliah, E., Hansen, L.A., Park, K. Friedman, P.J. 2000. Distribution of obstructive intimal lesions and their cellular phenotypes in chronic pulmonary hypertension: a morphometric and immunohistochemical study. Am J Respir Crit Care Med 162, 1577 1586.
66. Young, L.H., Renfu, Y., Russell, R., Hu, X., Caplan, M., Ren, J., Shulman, G.I. Sinusas, A.J. 1997. Low-flow ischemia leads to translocation of canine heart GLUT-4 and GLUT-1 glucose transporters to the sarcolemma in vivo. Circulation 95, 415 422.